JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Moore, K. E.
Right arrow Articles by Bert, J. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Moore, K. E.
Right arrow Articles by Bert, J. K.
Journal of Pharmacology And Experimental Therapeutics, Vol. 155, Issue 3, 506-515, 1967
Copyright © 1967 by American Society for Pharmacology and Experimental Therapeutics


TOXICOLOGIC STUDIES WITH agr-METHYLTYROSINE, AN INHIBITOR OF TYROSINE HYDROXYLASE

K. E. Moore 1, P. F. Wright 1, and J. K. Bert 1

1 Department of Pharmacology and Toxicology, Dartmouth Medical School, Hanover, New Hampshire

agr-Methyltyrosine (agrMT) has been used to deplete tissues of their catecholamine stores. After the intraperitoneal injection of 200 mg/kg of agrMT, 40% of the rats became depressed, lethargic, hypothermic and emaciated. These effects were marked by the 20th hr, and the animals died 28 to 48 hr after injection. Approximately 80% of rats receiving 300 mg/kg of agrMT were similarly affected. Rats exhibiting overt signs of toxicity had high blood urea nitrogen levels and excreted large volumes of urine with abnormally high contents of glucose and protein. These results, along with histologic evidence, were indicative of kidney damage. One consequence of this injury was the inability of the affected animals to excrete agrMT. The delayed death may result from renal damage per se or from the prolonged high concentration of agrMT in the tissues. The renal injury was prevented by repeated oral administration of water. When administered by the oral route (200 mg/kg) or by multiple intraperitoneal injections of small doses (50 mg/kg every 4 hr), agrMT depleted tissues of their catecholamine stores without producing concomitant renal damage and its sequelae.

Submitted on July 25, 1966
Accepted on September 27, 1966




This article has been cited by other articles:


Home page
ScienceHome page
D. E. Redmond Jr., I. W. Maas, A. Kling, C. W. Graham, and H. Dekirmenjian
Social Behavior of Monkeys Selectively Depleted of Monoamines
Science, October 22, 1971; 174(4007): 428 - 431.
[Abstract] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1967 by the American Society for Pharmacology and Experimental Therapeutics.